Browse > Article
http://dx.doi.org/10.7314/APJCP.2013.14.4.2269

Current Evidence on Associations Between the MMP-7 (-181A>G) Polymorphism and Digestive System Cancer Risk  

Ke, Pan (Department of General Surgery, Xiang-Ya 2nd Hospital, Central South University)
Wu, Zhong-De (Department of General Surgery, Xiang-Ya 2nd Hospital, Central South University)
Wen, Hua-Song (Department of General Surgery, Xiang-Ya 2nd Hospital, Central South University)
Ying, Miao-Xiong (Department of General Surgery, Xiang-Ya 2nd Hospital, Central South University)
Long, Huo-Cheng (Department of General Surgery, Xiang-Ya 2nd Hospital, Central South University)
Qing, Liu-Guo (Department of General Surgery, Xiang-Ya 2nd Hospital, Central South University)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.14, no.4, 2013 , pp. 2269-2272 More about this Journal
Abstract
Matrix metalloproteinases (MMPs) degrade various components of the extracellular matrix and functional polymorphisms in encoding genes may contribute to genetic susceptibility to many cancers. Up to now, associations between MMP-7 (-181A>G) and digestive system cancer risk have remained inconclusive. To better understand the role of the MMP-7 (-181A>G) genotype in digestive cancer development, we conducted this comprehensive meta-analysis encompassing 3,518 cases and 4,596 controls. Overall, the MMP-7 (-181A>G) polymorphism was associated with higher digestive system cancer risk on homozygote comparison (GG vs. AA, OR=1.21, 95% CI = 1.12-1.60) and in a dominant model (GG/GA vs. AA, OR=1.16, 95% CI =1.03-1.46). On subgroup analysis, this polymorphism was significantly linked to higher risks for gastric cancer (GG vs. AA, OR=1.22, 95% CI = 1.02-1.46; GA vs. AA, OR=1.82, 95% CI =1.16-2.87; GG/GA vs. AA, OR=1.13, 95% CI =1.01-1.27; GG vs. GA/AA, OR= 1.25, 95% CI = 1.06-2.39. We also observed increased susceptibility to colorectal cancer and esophageal SCC in both homozygote (OR = 1.13, 95% CI = 1.06-1.26) and heterozygote comparisons (OR = 1.45, 95% CI = 1.11-1.91). In the stratified analysis by controls, significant effects were only observed in population-based studies (GA vs. AA, OR=1.16, 95% CI=1.08-1.50; GA/AA vs. GG, OR=1.10, 95% CI=1.01-1.72). According to the source of ethnicity, a significantly increased risk was found among Asian populations in the homozygote model (GG vs. AA, OR=1.40, 95% CI=1.12-1.69), heterozygote model (GA vs. AA, OR=1.26, 95% CI=1.02-1.51), and dominant model (GG/GA vs. AA, OR=1.18, 95% CI=1.08-1.55). Our findings suggest that the MMP-7 (-181A>G) polymorphism may be a risk factor for digestive system cancer, especially among Asian populations.
Keywords
MMP-7; polymorphism; digestive cancer; meta-analysis; ethnic variation;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Bo P, Lihuan C, Xiaopin M, et al (2010). Meta-analysis of association between matrix metalloproteinases 2, 7 and 9 promoter polymorphisms and cancer risk. Mutagenesis, 25, 371-9.   DOI   ScienceOn
2 Li JY, Tian MM, Zhao AL (2008). Polymorphism in the promoter region of the metalloproteinase-7 increases susceptibility and risk of metastasis of gastric adenocarcinoma. Gastroenterology, 134, A603.
3 Li Y, Jin X, Kang S, et al (2006). Polymorphisms in the promoter regions of the matrix metalloproteinases-1,-3,-7, and-9 and the risk of epithelial ovarian cancer in China. Gynecol Oncol, 101, 92-6.   DOI   ScienceOn
4 Lievre A, Milet J, Carayol J, et al (2006). Genetic polymorphisms of MMP1, MMP3 and MMP7 gene promoter and risk of colorectal adenoma. BMC Cancer, 6, 270.   DOI
5 Malik MA, Sharma KL, Zargar SA, et al (2011). Association of matrix metalloproteinase-7 (-181A>G) polymorphism with risk of esophageal squamous cell carcinoma in Kashmir Valley. Saudi J Gastroenterol, 17, 301-6.   DOI
6 Malik MA, Zargar SA, Mittal B (2011). Role of the metalloproteinase-7 (181A>G) polymorphism in gastric cancer susceptibility: a case control study in Kashmir valley. Asian Pac J Cancer Prev, 12, 73-6.
7 Ohtani H, Maeda N, Murawaki Y (2009). Functional polymorphisms in the promoter regions of matrix metalloproteinase-2,-3,-7,-9 and TNF-alpha genes, and the risk of colorectal neoplasm in Japanese. Yonago Acta Medica, 52,47-56
8 Qiu W, Zhou G, Zhai Y, et al (2008). No association of MMP-7, MMP-8, and MMP-21 polymorphisms with the risk of hepatocellular carcinoma in a Chinese population. Cancer Epidemiol Biomarkers Prev, 17, 2514-8.   DOI   ScienceOn
9 Singh H, Jain M, Mittal B (2008). MMP-7 (-181A>G) promoter polymorphisms and risk for cervical cancer. Gynecol Oncol, 110, 71-5.   DOI   ScienceOn
10 Sugimoto M, Furuta T, Kodaira C, et al (2008). Polymorphisms of matrix metalloproteinase-7 and chymase are associated with susceptibility to and progression of gastric cancer in Japan. J Gastroenterol, 43,751-61.   DOI   ScienceOn
11 de Lima JM, de Souza LG, da Silva ID, et al (2009). E-cadherin and metalloproteinase-1 and-7 polymorphisms in colorectal cancer. Int J Biol Markers, 24, 99-106.
12 Dziki L, Przybylowska K, Majsterek I, et al (2011). A/G Polymorphism of the MMP-7 Gene Promoter Region in Colorectal Cancer. Pol Przegl Chir, 83, 622-6.
13 Fang W-L, Liang W-B, He H, et al (2010). Association of Matrix Metalloproteinases 1, 7, and 9 Gene Polymorphisms with Genetic Susceptibility to Colorectal Carcinoma in a Han Chinese Population. DNA Cell Biol, 29, 657-61.   DOI   ScienceOn
14 Ghilardi G, Biondi ML, Erario M, et al (2003). Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem, 49, 1940-2.   DOI   ScienceOn
15 Greenwald RJ, Oosterwegel MA, van der Woude D, et al (2002). CTLA-4 regulates cell cycle progression during a primary immune response. Eur J Immunol, 32, 366-73.   DOI
16 Hodi FS, Mihm MC, Soiffer RJ, et al (2003). Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci USA, 100, 4712-17.   DOI   ScienceOn
17 Jormsjo S, Whatling C, Walter DH, et al (2001). Allele specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholesterolemic patients. Arterioscler Thromb Vasc Biol, 21, 1834-39.   DOI   ScienceOn
18 Kim JH, Pyun JA, Lee KJ, et al (2011). [Study on association between single nucleotide polymorphisms of MMP7, MMP8, MMP9 genes and development of gastric cancer and lymph node metastasis]. Korean J Gastroenterol, 58, 245-51.   DOI   ScienceOn
19 Kubben FJGM, Sier CFM, Meijer MJW, et al (2006). Clinical impact of MMP and TIMP gene polymorphisms in gastric cancer. Br J Cancer, 95, 744-51.   DOI   ScienceOn
20 Vairaktaris E, Serefoglou Z, Yapijakis C, et al (2007). High gene expression of matrix metalloproteinase-7 is associated with early stages of oral cancer. Anticancer Res, 27, 2493-8.
21 Woo M, Park K, Nam J, et al (2007). Clinical implications of matrix metalloproteinase-1,-3,-7,-9,-12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol, 22, 1064-70.   DOI   ScienceOn
22 Wu S, Lu S, Tao H, et al (2011). Correlation of polymorphism of IL-8 and MMP-7 with occurrence and lymph node metastasis of early stage cervical cancer. J Huazhong Univ Sci Technol, 31, 114-9.   DOI   ScienceOn
23 Zhang J (2005). The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis, 26, 1748-53.   DOI   ScienceOn